HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...

Knockout or knockdown of expression or inhibition of these host factors can relieve the silencing, allowing for viral gene expression even in settings where HIV-1 DNA integration is blocked. When ...

10月25日，“十三五”国家科技重大专项成果——HIV-1 DNA载量检测试剂盒发布会在广州市黄埔区融媒体中心举办。本次会议由广州市创新领军团队携手广州海力特生物科技有限公司和暨南大学联合主办。海力特生物董事长、首席科学家朱托夫教授介绍，HIV ...

Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development ...

After removing the nucleos(t)ide analog reverse-transcriptase inhibitor monophosphate, the mode of DNA polymerization becomes active again (bottom). The P site and N site of HIV-1 reverse ...

Before initiating ART, VNPs showed significantly lower total and intact HIV-1 DNA levels in their peripheral blood ...

could help deplete the viral reservoir and eliminate it entirely in people living with HIV who receive antiretroviral ... Potential Link Between DNA Markers and Aging Process Aug. 19, 2024 ...

Gammora is a HIV-1 integrase-derived peptide that works to target the disease by stimulating the insertion of the virus’s ...

The structure of a catalytic complex of HIV–1 reverse transcriptase helps rationalize resistance mechanisms for nucleoside analog drugs.